Skip to main content

Profile hero

Profile details

About Sunil Singh

Sunil Singh is an Associate in Freshfields’ Commercial Disputes Group in London.

He has experience advising clients on a wide range of complex, large-scale disputes, both domestically and cross-border. He was part of the Freshfields team that won Commercial Litigation Team of the Year at the Legal Business Awards 2021 for the successful representation of a FinTech in a landmark dispute in the English Commercial Court arising from the COVID-19 pandemic (Travelport Ltd v Wex Inc [2020] EWHC 2670 (Comm)).

He also has experience advising clients on complex data privacy/cyber-security issues, including cyber-attacks, data breaches, ransomware attacks, state-sponsored attacks and follow-on data privacy/cyber-security litigation and regulatory investigations. He has advised various organisations including global FTSE 100 companies on the legal and regulatory regimes in the UK relating to responding to ransomware attacks and paying ransoms in the context of ransomware attacks.

During his time at Freshfields, Sunil has also spent time on secondment to the firm's New York office.

Recent work

  • Acting for a Bermuda investment fund in opposing a restructuring plan proposed under Part 26A of the Companies Act 2006 (Project Lietzenburger Strasse Holdco [2024] EWHC 468 (Ch)).

  • Acting for a sovereign wealth fund in a confidential emergency arbitration governed by the Rules of the International Chamber of Commerce.

  • Acting in a landmark dispute in the English Commercial Court advising a FinTech on the defence of litigation which concerned whether the effects of the COVID-19 pandemic were a Material Adverse Effect entitling it not to proceed with a $1.7bn acquisition of two e-payment companies (Travelport Ltd v Wex Inc [2020] EWHC 2670 (Comm)).

  • Acting for an international accounting firm in the defence of Commercial Court proceedings brought against it following the restatement of financial statements.

  • Advising a multinational company providing products and services to the pharmaceutical and healthcare markets with regards to an intellectual property dispute.

  • Advising a European FinTech on its cross-border response to a cyber-attack, including: (i) working with criminal, data protection and industry regulators in the UK and Germany; (ii) advising on litigation defence strategy; and (iii) working closely with cyber-forensic experts to mitigate risk.

  • Advising an independent investment group on its response to a global data breach stemming from a state-sponsored attack focused on collection of intelligence and commercial data relating to U.S- China policy.

  • Advising various organisations including global FTSE 100 companies on the legal and regulatory regimes in the US and the UK relating to responding to ransomware attacks and paying ransoms in the context of ransomware attacks.

  • Advising an NYSE-listed contract logistics provider on dispute resolution matters relating to its recommended public takeover offer for the entire issued share capital of a leading British supply chain solutions company.
      
  • Advising an independent investment group on litigation aspects relating to their disposal of the entire issued share capital in a water company for an equity value of £425m and an enterprise value of £814m.

  • Advising a global private equity firm on the enforceability of a global non-compete clause in a commercial agreement to manufacture and supply ursodeoxycholic acid for medical purposes. 

  • Advising a French private equity and investment advisory firm on litigation, anti-bribery and corruption and sanctions issues arising from its acquisition of a global medical device manufacturer.